Trial Profile
A Randomized Phase 2 Single-Center Study of Pomalidomide for Chronic GvHD
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2020
Price :
$35
*
At a glance
- Drugs Pomalidomide (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 24 Sep 2020 Results published in the Blood
- 04 Jun 2019 Status changed from active, no longer recruiting to completed.
- 10 Aug 2018 Planned End Date changed from 1 Jul 2018 to 31 Mar 2019.